Ergomed plc is a provider of pharmacovigilance and specialist clinical trial solutions to the pharmaceutical and biotechnology industries. The company operates its business through two segments – Clinical Research Services (CRO) and Pharmacovigilance (PV). CRO is the outsourced management of clinical research to specialist service providers who organise all aspects of a clinical trial, including the creation and management of the trial team, recruitment of medical experts, patient recruitment, regulatory affairs, medical writing, quality management, and pharmacovigilance. It offers clinical research and trial management services in all trial phases (I to IV) through the Ergomed brand. Ergomed specialises in managing oncology and rare disease trials and provides site-support services with focus on improving patient recruitment and engagement. The PV segment consists of other drug lifecycle services gcovering medical information and qualified person responsible for pharmacovigilance (QPPV) networks. It offers PV services to clients under the PrimeVigilance brand and covers case processing, signal and risk management, pharmacoepidemiology, audits, training, advisory literature services, medical information, and QPPV. PrimeVigilance assists pharmaceutical, biotechnology, and genetics companies in managing the safety of their products from clinical trial to post-marketing. The company focuses on intelligent automation to provide faster analysis and reporting of adverse medical events. Ergomed, through ADAMAS Consulting, offers complementary regulatory compliance audit services for the pharmaceutical industry including – good clinical practice (GCP), good pharmacovigilance practice (GVP), good manufacturing practice (GMP), good laboratory practice (GLP), and computer systems compliance (CSC).
You have successfully subscribed and will receive the next available issues